-
141
Progress on responsive neurostimulation in treatment of drug⁃resistant epilepsy
Published 2025-01-01Get full text
Article -
142
Immunosuppression Induced by Chronic Inflammation and the Progression to Oral Squamous Cell Carcinoma
Published 2016-01-01Get full text
Article -
143
-
144
-
145
-
146
Multicenter study for CH-VAD as a fully magnetically levitated left ventricular assist device
Published 2025-02-01Get full text
Article -
147
-
148
-
149
-
150
-
151
Prognostic Significance and Therapeutic Potential of SERPINE1 in Head and Neck Squamous Cell Carcinoma
Published 2025-01-01Get full text
Article -
152
-
153
-
154
Inosine enhances the efficacy of immune‐checkpoint inhibitors in advanced solid tumors: A randomized, controlled, Phase 2 study
Published 2024-09-01“…Methods This single‐center, prospective, randomized, open‐label study was conducted, from January 2021 to December 2022, in Beijing Friendship Hospital, Capital Medical University, and participants were randomly assigned (1:1) to either the inosine (trial) or non‐inosine (control) group that received inosine (dosage: 0.2 g, three times/day) + PD‐1/PD‐L1 inhibitor or only PD‐1/PD‐L1 inhibitor ± targeted ± chemotherapy, respectively. …”
Get full text
Article -
155
-
156
-
157
Genetic Predisposition and Salt Sensitivity in a Chinese Han Population: The EpiSS Study
Published 2020-01-01Get full text
Article -
158
-
159
-
160
Clinical Profile and Outcome in Patients with Coronary Slow Flow Phenomenon
Published 2019-01-01Get full text
Article